What is Medicenna Therapeutics Corp?
, a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company is listed on the OTCQX in USA, operating in the Healthcare sector, with a market capitalisation of 54.81M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.